These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 25407552)

  • 1. Cocrystals of acyclovir with promising physicochemical properties.
    Sarkar A; Rohani S
    J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
    Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
    Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and physicochemical characterization of acyclovir cocrystals with improved dissolution properties.
    Bruni G; Maietta M; Maggi L; Mustarelli P; Ferrara C; Berbenni V; Milanese C; Girella A; Marini A
    J Pharm Sci; 2013 Nov; 102(11):4079-86. PubMed ID: 24030886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Characterization and Pharmaceutical Properties of Three Novel Cocrystals of Ethenzamide With Aliphatic Dicarboxylic Acids.
    Kozak A; Marek PH; Pindelska E
    J Pharm Sci; 2019 Apr; 108(4):1476-1485. PubMed ID: 30414866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
    Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrofurantoin-p-aminobenzoic acid cocrystal: hydration stability and dissolution rate studies.
    Cherukuvada S; Babu NJ; Nangia A
    J Pharm Sci; 2011 Aug; 100(8):3233-3244. PubMed ID: 21425165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal engineering of stable temozolomide cocrystals.
    Babu NJ; Sanphui P; Nangia A
    Chem Asian J; 2012 Oct; 7(10):2274-85. PubMed ID: 22615256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular salts and co-crystals of mirtazapine with promising physicochemical properties.
    Sarkar A; Rohani S
    J Pharm Biomed Anal; 2015 Jun; 110():93-9. PubMed ID: 25818704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical stability enhancement of theophylline via cocrystallization.
    Trask AV; Motherwell WD; Jones W
    Int J Pharm; 2006 Aug; 320(1-2):114-23. PubMed ID: 16769188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocrystal habit engineering to improve drug dissolution and alter derived powder properties.
    Serrano DR; O'Connell P; Paluch KJ; Walsh D; Healy AM
    J Pharm Pharmacol; 2016 May; 68(5):665-77. PubMed ID: 26408342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal engineering to improve physicochemical properties of mefloquine hydrochloride.
    Yadav AV; Dabke AP; Shete AS
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1036-45. PubMed ID: 20334542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
    Remenar JF; Morissette SL; Peterson ML; Moulton B; MacPhee JM; Guzmán HR; Almarsson O
    J Am Chem Soc; 2003 Jul; 125(28):8456-7. PubMed ID: 12848550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
    Ober CA; Gupta RB
    AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization and dissolution profile of mycophenolic acid cocrystals.
    Zeng QZ; Ouyang J; Zhang S; Zhang L
    Eur J Pharm Sci; 2017 May; 102():140-146. PubMed ID: 28254392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing of Stable Co-crystals of Zoledronic Acid Using Suitable Coformers.
    Varma A; Laxmi P; Pai A; Pai G; Sg V; Badamane Sathyanarayana M
    Chem Pharm Bull (Tokyo); 2019; 67(8):816-823. PubMed ID: 31366831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Salt-Cocrystals of Berberine Hydrochloride with Aliphatic Dicarboxylic Acids: Odd-Even Alternation in Physicochemical Properties.
    Wang L; Liu S; Chen JM; Wang YX; Sun CC
    Mol Pharm; 2021 Apr; 18(4):1758-1767. PubMed ID: 33656348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocrystal and Salt Forms of an Imidazopyridazine Antimalarial Drug Lead.
    Noonan TJ; Chibale K; Cheuka PM; Bourne SA; Caira MR
    J Pharm Sci; 2019 Jul; 108(7):2349-2357. PubMed ID: 30817923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.